Skip to main content
    I

    Immatics NV (IMTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.29
    +0.12 (+1.94%)

    Market Cap: $939.49M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Immatics NV (IMTX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Immatics NV (IMTX) has a market cap of $939.49M. It kept -534.13% of revenue as net income over the last 12 months. Its share count is up 18.67% from a year earlier.

    Total Valuation

    Market Cap$939.49M
    Latest price (Nov 17, 2026)$6.29

    Key Dates

    The next earnings report is expected on Mar 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 3, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.55% in the quarter ended Sep 30, 2026 and grew 14.37% a year over 2 years.

    Shares Outstanding144.26M
    Shares Change (YoY)+18.67%
    Shares Change (QoQ)+5.55%
    Share Count Growth (2Y CAGR)+14.37%

    Valuation Ratios

    Sales and book value multiples are 18.0x and 1.8x. Its year-end P/S ranged from 1.5x to 23.6x from 2020 to 2025.

    P/S Ratio18.0x
    P/B Ratio1.8x
    P/TBV Ratio1.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 38.33% over 52 weeks and trades 17.02% below its 50-day average.

    Beta (1Y)1.45
    52-Week Change-38.33%
    1-Month Change-10.78%
    3-Month Change-32.00%
    6-Month Change-41.22%
    5-Year Change-49.76%
    Total Return (1Y)-38.33%
    Total Return (3Y CAGR)-10.18%
    Total Return (5Y CAGR)-12.37%
    Return vs SPY (1Y)-50.61%
    Max Drawdown (1Y)-48.02%
    Max Drawdown (3Y)-74.05%
    Sharpe Ratio (1Y)-0.91
    Correlation with SPY (1Y)0.37
    50-Day Average$7.58
    200-Day Average$9.39
    52-Week Range$6.07 to $12.41
    RSI (14 Days)36.2
    Average Volume (20 Days)1.17M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.03x current liabilities.

    Current Ratio5.03x
    Quick Ratio5.03x
    Interest Coverage25.09x

    Returns and Efficiency

    Return on equity is -53.59% over the last 12 months, against a 5-year average of -91.14%.

    Return on Equity (ROE)-53.59%
    Return on Assets (ROA)-41.54%
    Return on Capital Employed (ROCE)-49.93%
    ROE (5Y Average)-91.14%
    ROA (5Y Average)-19.59%
    ROIC (5Y Average)-82.54%
    Asset Turnover0.08x
    Receivables Turnover3.02x

    Scores

    IMTX has an Altman Z-Score of 0.92, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score0.92
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of EUR 43.44M over the last 12 months is down 48.75% from the 12 months before.

    RevenueEUR 43.44M
    Revenue Growth (YoY)-48.75%
    Gross ProfitEUR 43.44M
    Operating IncomeEUR -250.69M
    Pretax IncomeEUR -232.52M
    Net IncomeEUR -232.03M
    EBITDAEUR -219.81M
    EBITEUR -231.68M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 77.51% of the EUR 565.72M in total assets.

    Working CapitalEUR 409.27M
    Shareholder EquityEUR 438.50M
    Tangible Book ValueEUR 436.84M
    Total AssetsEUR 565.72M
    Total LiabilitiesEUR 127.22M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash FlowEUR -222.27M
    Depreciation and AmortizationEUR 11.87M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -577.10%.

    Gross Margin100.00%
    Operating Margin-577.10%
    Pretax Margin-535.27%
    Net Margin-534.13%
    EBITDA Margin-506.01%
    EBIT Margin-533.34%

    Growth

    Revenue fell 34.64% a year over 3 years.

    Revenue Growth (3Y CAGR)-34.64%
    Revenue Growth (5Y CAGR)+9.08%

    Revenue and profit by year

    Peer Position

    Against 7 similar companies, IMTX has the 4th highest P/S.

    P/S Ratio18.0x vs 8.4x median
    Revenue Growth (Trailing 4 Quarters, YoY)-48.75% vs -61.33% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IMTX

    What is IMTX's market cap?

    Immatics NV has a market cap of $939.49M.

    How many shares of IMTX are outstanding?

    Immatics NV has 144.26M shares outstanding. The count is up 18.67% from a year earlier.

    Does IMTX pay a dividend?

    No. Immatics NV does not pay a dividend.